Detalle de: Corrigendum to “Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile” [Pharmacol. Res. 110 (August 2016) (2016) 205–215]
| Title | Corrigendum to “Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile” [Pharmacol. Res. 110 (August 2016) (2016) 205–215] |
| Abstract | |
| Apa Reference | Gómez-Cañas, M., Morales, P., García-Toscano, L., Navarrete, C., Muñoz, E., Jagerovic, N., Fernández-Ruiz, J., García-Arencibia, M. & Pazos, M. (2017). Corrigendum to “Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile” [Pharmacol. Res. 110 (August 2016) (2016) 205–215]. Pharmacological Research, 120, 302. 10.1016/j.phrs.2017.04.002 |
| Doi | 10.1016/j.phrs.2017.04.002 |
| Publication Date | Jun 2017 |
| Publication Type | Article |
| Researcher | Paula Morales |
| Ontology | |
| Research Groups | |
| Tools |